Let’s take a look at some of the health tech updates from around the world, covering the latest investments to EHR roll-outs.
AI platform Ambience Healthcare receives $243 million in Series C funding
US-based AI company, Ambience Healthcare has secured $243 million in Series C funding to continue expanding its AI platform across health systems, to help make “care teams more effective everywhere” and “accelerate the delivery of products”. The platform was developed to support documentation and coding as a way to improve clinical workflow throughout healthcare, integrating with different EHR systems and adapting to the “unique context of each care setting and specialty without requiring workflow redesign or staff retraining”.
The new round of funding was co-led by Oak HC/FT and Andreessen Horowitz (a16z), with existing investors OpenAI Startup Fund, Kleiner Perkins, and Optum Ventures.
13 healthcare facilities in North Carolina go live with Epic EHR system
The North Carolina Department of Health and Human Services (NCDHHS) has introduced an EHR system powered by Epic to 13 different state-operated healthcare facilities across North Carolina, with the aim to offer “improved and more comprehensive care”. The NCDHHS is also hoping that the implementation of this system will help to streamline processes for staff, enhance security for the protection of patient data and improve regulatory compliance.
According to NCDHHS, the system went live on 1 August 2025 and is providing “easy access to test results, medications, and medical history” for both clinicians and patients. Other notable benefits include a reduction in delays and repeated tests, as well as improved safety and more coordinated care, with some healthcare facilities also allowing patients to access their health information through the MyChart online portal.
“At Cherry Hospital, our mission is to provide excellent psychiatric care to individuals with the greatest need and the fewest resources. By implementing electronic health records, our staff can spend less time on paperwork and more time focusing on what matters most—caring for our patients,” Timothy Miller, CEO, Cherry Hospital, said.
Cyted Health secures $44 million in its Series B funding for expansion into the US
The gastrointestinal molecular diagnostics company, Cyted Health has received $44 million in its Series B funding as part of its latest efforts to increase its ongoing expansion into the US market. After already seeing “significant success” in the UK, the company reportedly wants to continue to develop its portfolio and “accelerate the commercial expansion” of its diagnostic platform by using the funding that was led by EQT Life Sciences.
CEO and co-founder of Cyted Health, Marcel Gehrung, commented: “This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio.”
EliseAI $250 million in Series E funding to support expansion and product innovation
New York software and AI company, EliseAI has announced $250 million in Series E funding to support plans for rapid expansion and continued product innovation of their automation platform. According to the company, the investment will help with “improving patient experiences, streamlining operations, and advancing AI-driven solutions for customers”.
As part of their expansion plans, EliseAI is now “actively hiring across all departments” while also increasing its office space across New York, San Francisco, Boston and Chicago, following on from its previous round of funding which has helped them go from 150 to 300 employees since August 2024. The company also plans to use the funding to improve their automation platform, noting how they will be “doubling down on healthcare” by tackling administrative tasks taking place in front-desk and call centre operations.
The venture capital firm, Andreessen Horowitz led this round of funding, with support from Bessemer Venture Partners, Sapphire Ventures and Navitas Capital.
$12 million in Series A funding awarded to C8 Health to develop additional AI capabilities
C8 Health, the clinical best practices platform, has received $12 million in Series A funding, led by venture capital fund Team8, with participation from 10D and Vertex Ventures Israel. The company plans to use the investment to expand their engineering and go-to-market teams, emphasising the importance of scaling their impact by ensuring “every hospital that adopts C8 joins a growing global network where best practices flow freely between institutions”.
They’ve also outlined a need to develop additional capabilities for their AI assistant in order to make it “even easier” for clinicians to receive instant and accurate answers to their questions. Speaking on the importance of this round of funding, C8 Health CEO Galia Rosen Schwarz, said: “It is exciting to see how we enable hospitals to implement their best practices effectively and gain control over both care quality and delivery costs. This round will help us grow our team to support the needs and demand in the market.”
